Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The new chart & the 450 days duration % numbers.

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Apr 29, 2023 5:16pm

148 Views

Post# 35421127

RE:RE:RE:The new chart & the 450 days duration % numbers.

Eoganacht...I just wanted to add that in addition to your contributions, I am also very thankful for Keytruda & Adstiladrin in having provided us a new "FDA-approved" durable response standard of 19% to 24%...a pretty low threshold to overcome, & imo, our chances for approval have gone up significantly thanks to them, especially when you consider there is still a dire need for an effective lower-cost & more reasonable/patient-friendly treatment option.

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition